Pig Semen-Derived Eye Drops Shrink Childhood Eye Cancer Tumors by 97%

Chinese researchers develop a novel cancer treatment using exosomes extracted from pig reproductive fluid.

Apr. 3, 2026 at 5:23pm

Got story updates? Submit your updates here. ›

A bold, abstract painting in muted earth tones featuring sweeping geometric shapes, concentric circles, and precise botanical spirals, conceptually representing the complex biological and chemical forces involved in using pig semen-derived exosomes to deliver cancer-fighting nanoparticles to retinal tumors.Pig biology inspires a revolutionary eye drop treatment that harnesses the power of reproductive exosomes to target and shrink childhood eye cancer tumors.Los Angeles Today

Researchers in China have developed a groundbreaking eye drop treatment for retinoblastoma, a type of childhood eye cancer, using exosomes extracted from pig semen. The exosomes are able to penetrate the eye's natural barriers and deliver cancer-fighting nanoparticles directly to tumor sites, shrinking tumors by an unprecedented 97% in mouse studies without causing any tissue damage or vision impairment.

Why it matters

Retinoblastoma remains a leading cause of childhood cancer deaths in low-income countries due to limited access to specialized oncology centers and complex treatment procedures. This new eye drop approach using pig-derived exosomes could provide a simple, affordable, and widely accessible treatment option to address this global health disparity.

The details

The research team, led by Yu Zhang at Shenyang Pharmaceutical University, leveraged the natural properties of exosomes found in pig reproductive fluid to create a targeted cancer therapy. These microscopic extracellular vesicles are able to hijack the eye's own growth factor receptors, slipping through the cornea and conjunctiva like 'molecular Trojan horses' to deliver their cargo of cancer-killing nanoparticles directly to retinal tumor sites.

  • The mouse study demonstrated a 97% reduction in retinoblastoma tumor size after 30 days of eye drop treatment.
  • Researchers noted that carbon dot nanoparticles have shown promise for cancer therapy due to their enzyme-like activity and high safety profile.

The players

Yu Zhang

Lead researcher at Shenyang Pharmaceutical University who led the development of the pig semen-derived eye drop treatment for retinoblastoma.

Shenyang Pharmaceutical University

The Chinese university where the research team is based and where the novel eye drop treatment was developed.

Got photos? Submit your photos here. ›

What they’re saying

“This led us to explore whether semen-derived exosomes also possess the ability to penetrate ocular barriers.”

— Yu Zhang, Researcher

“Carbon dots have emerged as a promising approach for cancer therapy, owing to their enzyme-like activity and high safety profile.”

— Yu Zhang, Researcher

What’s next

Human trials for the pig semen-derived eye drop treatment face regulatory challenges around batch consistency, immune reactions, and approval for using xenogeneic biologics, but researchers are optimistic about the potential to expand the treatment beyond retinoblastoma to other eye diseases like macular degeneration and diabetic retinopathy.

The takeaway

This innovative use of pig reproductive biology to create a simple, accessible eye drop treatment for a deadly childhood cancer demonstrates the power of looking to unexpected sources for medical breakthroughs. If successful in human trials, this approach could save lives worldwide by providing an affordable, non-invasive therapy that overcomes the barriers limiting access to current retinoblastoma treatments.